About Etanercept (ERELZI)
            
            Class: | Tumor Necrosis Factor (TNF) Inhibitor  
Use: | Treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and juvenile idiopathic arthritis  
Adult dose: | 50 mg subcutaneously once weekly  
Pediatric dose: | For juvenile idiopathic arthritis, 0.8 mg/kg subcutaneously once weekly (maximum 50 mg)  
Side effects: | Injection site reactions, headache, nausea, increased risk of infections, elevated liver enzymes, and allergic reactio
         
        
            
                
                
                    
                        Drug Class
                    
                    Tumor Necrosis Factor (TNF) Inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and juvenile idiopathic arthritis
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; may be stored at room temperature (up to 25°C or 77°F) for a maximum of 14 days
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Sandoz GmbH, AUSTRIA
                    
                    
                    Package Size
                    1ml Prefilled Pens (50mg) x 4
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 3001.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        50 mg subcutaneously once weekly
                    
                    
                        Pediatric Dose
                    
                    
                        For juvenile idiopathic arthritis, 0.8 mg/kg subcutaneously once weekly (maximum 50 mg)
                    
                 
                
                
                    
                        Side Effects
                    
                    Injection site reactions, headache, nausea, increased risk of infections, elevated liver enzymes, and allergic reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Active infections, sepsis, hypersensitivity to etanercept or any component of the formulation, and concurrent use with other biologic DMARDs or live vaccines
         
        
        
            
                Important Warnings
            
            Risk of serious infections, including tuberculosis; malignancies; heart failure; and demyelinating disorders; monitor for signs of infection and malignancy during treatment
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.